We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Spirituality, Religiosity, and Immune Functioning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00066924
Recruitment Status : Completed
First Posted : August 8, 2003
Last Update Posted : June 24, 2005
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine whether religiosity and spirituality are related to immune functioning, as measured by interleukin-6 blood plasma level, among terminally ill cancer patients.

Condition or disease
Cancer Depression Dying Process

Study Design

Study Type : Observational
Estimated Enrollment : 120 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Study Start Date : September 2003
Estimated Study Completion Date : June 2004
Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Inpatient at Calvary Hospital
  • Diagnosis of terminal cancer
  • Score of 20 or above on Mini-Mental State Exam

Exclusion criteria:

  • Presence of a psychiatric disorder that would preclude the production of meaningful data
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00066924


Locations
United States, New York
Calvary Hospital
Bronx, New York, United States
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Principal Investigator: Barry Rosenfeld, PhD Fordham University
Principal Investigator: William Breitbart, MD Memorial Sloan Kettering Cancer Center
More Information

Publications:
ClinicalTrials.gov Identifier: NCT00066924     History of Changes
Other Study ID Numbers: F31AT001769-01 ( U.S. NIH Grant/Contract )
First Posted: August 8, 2003    Key Record Dates
Last Update Posted: June 24, 2005
Last Verified: May 2005

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
spirituality
religiosity
immune functioning
psychoneuroimmunology
cytokines
cancer
death
depression

Additional relevant MeSH terms:
Depression
Behavioral Symptoms